Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
Clinical trial NCT06277037 · RECRUITING
Trial details
- NCT number
- NCT06277037
- Sponsor
- Arbutus Biopharma Corporation
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-11
- Primary completion
- 2029-08-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.